Table 2 Characteristics of patients with and without SB
From: Prospective assessment of subjective sleep benefit in Parkinson’s disease
SB based on diary | SB based on questionnaire | |||||
|---|---|---|---|---|---|---|
SB | no-SB | p | SB | no-SB | p | |
SB | 76 (32%) | 159 (68%) | 74 (31%) | 163 (69%) | ||
Men | 43 (57%) | 94 (59%) | 0.741 | 37 (50%) | 102 (63%) | 0.068 |
Age (yrs) | 67.3 ± 9.7 | 66.3 ± 9.6 | 0.454 | 63.6 ± 8.2 | 68.5 ± 9.7 | 0.000* |
Age PD onset (yrs) | 56.6 ± 13.6 | 57.5 ± 11.5 | 0.587 | 51.9 ± 11.1 | 60.0 ± 11.9 | 0.000* |
Duration of PD symptoms (yrs) | 10.8 ± 7.0 | 8.7 ± 5.8 | 0.019 | 11.7 ± 6.7 | 8.2 ± 5.7 | 0.000* |
Duration medication use (yrs) | 9.0 ± 6.0 | 6.8 ± 5.5 | 0.009* | 9.4 ± 6.3 | 6.5 ± 5.3 | 0.001* |
Daily LED (mg) | 752 ± 608 | 624 ± 409 | 0.080 | 804 ± 614 | 584 ± 382 | 0.002* |
PSQI | 7.5 ± 3.9 | 7.2 ± 3.9 | 0.680 | 7.8 ± 4.1 | 7.0 ± 3.8 | 0.178 |
Sleep duration (hrs - PSQI) | 6.7 ± 1.3 | 6.7 ± 1.6 | 0.960 | 6.4 ± 1.3 | 6.8 ± 1.5 | 0.039 |
Sleep efficiency (% - PSQI) | 78.7 ± 16.1 | 78.2 ± 17.7 | 0.840 | 74.9 ± 14.7 | 80.3 ± 17.9 | 0.027 |